Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: A promising cancer biomarker assay

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 995-1000

  Shivapurkar, Narayan ^a,b   Stastny, Victor ^a   Xie, Yang ^a   Prinsen, Clemens ^c   Frenkel, Eugene ^b   Czerniak, Bogdan ^d   Thunnissen, Frederik B ^c   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CPG ISLAND; DNA SEQUENCE; EARLY DIAGNOSIS; EXON; HUMAN; HUMAN TISSUE; LUNG CANCER; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM ANALYSIS; TCF21 GENE; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA METHYLATION; EXONS; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149114024     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2808     Document Type: Article

References (22)

1. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
2. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-219.
3. Eads CA, Nickel AE, Laird PW. Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice. Cancer Res 2002;62:1296-9.
4. Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001;61:3410-8.
5. Brabender J, Usadel H, Danenberg KD, et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001;20:3528-32.
6. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
7. Harden SV, Tokumaru Y, Westra WH, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage Ilung cancer patients. Clin Cancer Res 2003;9:1370-5.
8. Topaloglu O, Hoque MO, Tokumaru Y, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004;10:2284-8.
9. Shivapurkar N, Stastny V, Suzuki M, et al. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 2007;247:56-71.
10. Quaggin SE, Schwartz L, Cui S, et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999;126:5771-83.
11. Smith LT, Lin M, Brena RM, et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-24 in lung and head and neck cancer. Proc Natl Acad Sci U S A 2006;103:982-7.
12. Shigematsu H, Suzuki M, Takahashi T, et al. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer 2005;113:600-4.
13. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
14. Shigematsu H, Takahashi T, Nomura M, et al. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res 2005;65:1642-6.
15. Toyooka KO, Toyooka S, Maitra A, et al. Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol 2002;161:629-34.
16. Shivapurkar N, Stastny V, Takahashi T, et al. Novel real-time PCR assay using a universal molecular marker for diagnosis of hematologic cancers. Int J Cancer 2005;116:656-60.
17. Fackler MJ, McVeigh M, Mehrotra J, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004;64:4442-52.
18. Ramirez RD, Sheridan S, Girard L, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004;64:9027-34.
19. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005;15:490-5.
20. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-83.
21. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007;39:305-18.
22. Taki M, Kamata N, Yokoyama K, et al. Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 2003;94:593-7.